Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to MSD innovators at OxTALENT 2017

Innovation

The OxTALENT annual awards recognise members of the University who have made innovative use of digital technology in learning/teaching and outreach/public engagement.

MSD innovators took all three places on the podium in the Public Engagement category [http://blogs.it.ox.ac.uk/oxtalent/2996]

 Winners: Andrew Pollard, Sarah Loving & Yama Farooq for The Vaccine Knowledge Project

Runners-up: Scott Billings, Ellena Smith, Kate Nation, Jacqueline Pumphrey, Zoltan Molnar & Holly Bridge for Brain Diaries

Honourable Mention: Chris Paton, Mike English, Hilary Edgcombe, Niall Winters, Anne Geniets & Jakob Rossner for LIFE: Life-Saving Instruction for Emergencies

 MSD also received awards in:

 Innovative teaching and learning with technology [http://blogs.it.ox.ac.uk/oxtalent/2990]

 Joint Runners-up: Nicola Barclay, Simon Kyle, Colin Espie, Christopher-James Harvey, Sumathi Sekaran & Damion Young for The Oxford online programme in Sleep Medicine

Honourable Mention: Jennifer Brown for Development of ‘Virtual Microscopy’ and online assessment modules for the Laboratory Medicine course

 Innovation Challenges [http://blogs.it.ox.ac.uk/oxtalent/3033]

 Runner-up: Jon Mason for Chooser: Simple, flexible option choosing

 

 

Similar stories

New blood-based test is the first ever to simultaneously identify if a patient has cancer and if it has spread

A publication by University of Oxford researchers describes a new minimally invasive and inexpensive blood test that can identify cancer in patients with non-specific symptoms. The early success of this technology makes it the first blood-based test that not only detects cancer in this population but can simultaneously identify if a cancer has spread.

Alan Davidson Foundation supports ground-breaking Motor Neurone Disease research

A £210,000 donation from the Alan Davidson Foundation (ADF) has been made to the Nuffield Department of Clinical Neurosciences (NDCN) to advance the University’s world leading research into Motor Neurone Disease (MND). The funding will support a project manager for three years to deliver an innovative research project using the genetic causes of MND to develop approaches to early diagnosis and eventually, prevention of all forms of MND.

New Oxford-GSK Institute to harness advanced technology and unravel mechanisms of disease

GlaxoSmithKline plc and the University of Oxford today announced a major five-year collaboration to establish the Oxford-GSK Institute of Molecular and Computational Medicine.

Jenner Institute named Covid Innovation Heroes

The team at the University of Oxford’s Jenner Institute has been celebrated for their global pandemic work by The Oxford Trust’s Covid Innovation Heroes Award­ 2021.

Oxford joins consortium to advance quantum drug discovery with £6.8M grant from Innovate UK

Oxford University today joins a consortium led by the digital quantum computing company, SEEQC, to build and deliver a full-stack quantum computer for pharmaceutical drug development for Merck KGaA.

AIMday in Women's Health - registration for academics now open

Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes? If you answer YES to any of the above, now is the time to register for the AIMday in Women's Health.